Is Shin Nippon Biomedical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Shin Nippon Biomedical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY20 per share. Over the last 17 times between 2004 and 2024, Shin Nippon Biomedical has paid JPY172 with an average of JPY10.12 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Shin Nippon Biomedical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY699.00, you would have made a profit of JPY459.00 per share or 65.67%
Yes, the average daily trading liquidity for Shin Nippon Biomedical is JPY321 771 thousand. You should therefore be able to get in and out of your positions relatively fast.
Shin Nippon Biomedical has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.10, the company's ability to pay off the debt is normal. Shin Nippon Biomedical has a very good net profit margin of 20.91% and should have very high tolerances against inflation.
We have calculated the inflation risk for Shin Nippon Biomedical to be low [0.3 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.